Experts: Social Media Pose a Compliance Risk

Use of internet-based social media such as Facebook and Twitter can pose compliance risks for drug companies, experts agree. “It’s not the media but the message — and regulatory guidelines are as unclear for the agencies as for the industry,” Mark DeWyngaert, managing director of the Huron Consulting Group, said at the Food and Drug Law Institute’s 21st annual Advertising & Promotion Conference.
Drug Industry Daily